S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 301 to 360 of 563

Issue Date	Title / Author(s) / Citation	File
2016-06	Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy? Park, H. J.; Kim, K.; Paik, J. H.; Chie, E. K.; Kim, S.; Jang, J. -Y.; Kim, S. W.; Han, S. -W.; Oh, D. -Y.; Im, S. -A.; Kim, T. -Y.; Bang, Y. -J.; Ha, S. W. Clinical and Translational Oncology, Vol.18 No.6, pp.625-631	DOI
2016-06	5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial Gianni, Luca; Pienkowski, Tadeusz; Im, Young-Hyuck; Tseng, Ling-Ming; Liu, Mei-Ching; Lluch, Ana; Staroslawska, Elzbieta; de la Haba-Rodriguez, Juan; Im, Seock-Ah; Pedrini, Jose Luiz; Poirier, Brigitte; Morandi, Paolo; Semiglazov, Vladimir; Srimuninnimit, Vichien; Bianchi, Giulia Valeria; Magazzu, Domenico; McNally, Virginia; Douthwaite, Hannah; Ross, Graham; Valagussa, Pinuccia The Lancet Oncology, Vol.17 No.6, pp.791-800	DOI
2016-06	Prognostic role of body mass index in advanced small bowel adenocarcinoma patients receiving palliative chemotherapy Lee, Dae-Won; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Nutrition and Cancer, Vol.68 No.5, pp.750-755	DOI
2016-07	Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer Lee, Eun-Shin; Han, Wonshik; Kim, Min Kyoon; Kim, Jongjin; Yoo, Tae-Kyung; Lee, Moo Hyun; Lee, Kyung Hun; Kim, Tae Yong; Moon, Hyeong-Gon; Im, Seock-Ah; Noh, Dong-Young; Lee, Eun Sook BMC Cancer, Vol.16, p. 430	view file DOI
2016-07	Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer Cha, Yongjun; Kim, Kyung-Ju; Han, Sae-Won; Rhee, Ye Young; Bae, Jeong Mo; Wen, Xianyu; Cho, Nam-Yun; Lee, Dae-Won; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Jeong, Seung-Yong; Park, Kyu Joo; Kang, Gyeong Hoon; Kim, Tae-You British Journal of Cancer, Vol.115 No.2, pp.164-171	DOI
2016-07	Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX Kim, Mi-Jung; Han, Sae-Won; Lee, Dae-Won; Cha, Yongjun; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Kim, Se Hyung; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Cancer Research and Treatment, Vol.48 No.3, pp.990-997	DOI
2016-07	Concurrent chemoradiotherapy versus chemotherapy alone for unresectable locally advanced pancreatic cancer: A retrospective cohort study Choi, Younak; Oh, Do-Youn; Kim, Kyubo; Chie, Eui Kyu; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Ha, Sung Whan; Bang, Yung-Jue Cancer Research and Treatment, Vol.48 No.3, pp.1045-1055	DOI
2016-07	Safety and tolerability of etirinotecan pegol in advanced breast cancer: analysis of the randomized, phase 3 BEACON trial Cortes, Javier; Rugo, Hope S.; Twelves, Chris; Awada, Ahmad; Perez, Edith A.; Im, Seock-Ah; Zhao, Carol; Hoch, Ute; Tomkinson, Denise; Buchanan, James; Tagliaferri, Mary; Hannah, Alison; O'Shaughnessy, Joyce SpringerPlus, Vol.5, p. 1033	DOI
2016-07	Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses Yang, Yaewon; Im, Seock-Ah; Keam, Bhumsuk; Lee, Kyung-Hun; Kim, Tae-Yong; Suh, Koung Jin; Ryu, Han Suk; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Kim, Tae-You; Park, In Ae; Noh, Dong-Young BMC Cancer, Vol.16, p. 515	DOI
2016-07	Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer Suh, Koung Jin; Ryu, Han Suk; Lee, Kyung-Hun; Kim, Hyojin; Min, Ahrum; Kim, Tae-Yong; Yang, Yaewon; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Im, Seock-Ah Breast Cancer Research and Treatment, Vol.158 No.2, pp.233-241	DOI
2016-07	Src as a Therapeutic Target in Biliary Tract Cancer Nam, Ah-Rong; Kim, Ji-Won; Park, Ji Eun; Bang, Ju-Hee; Jin, Mei Hua; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.15 No.7, pp.1515-1524	DOI
2016-07	Early prediction of response to neoadjuvant chemotherapy in breast cancer patients: comparison of single-voxel H-1-magnetic resonance spectroscopy and F-18-fluorodeoxyglucose positron emission tomography Cho, Nariya; Im, Seock-Ah; Kang, Keon Wook; Park, In-Ae; Song, In Chan; Lee, Kyung-Hun; Kim, Tae-Yong; Lee, Hyunjong; Chun, In Kook; Yoon, Hai-Jeon; Moon, Woo Kyung European Radiology, Vol.26 No.7, pp.2279-2290	DOI
2016-08	Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancer Jin, Min-Sun; Lee, Hyebin; Park, In Ae; Chung, Yul Ri; Im, Seock-Ah; Lee, Kyung-Hun; Moon, Hyeong-Gon; Han, Wonshik; Kim, Kyubo; Kim, Tae-Yong; Noh, Dong-Young; Ryu, Han Suk Virchows Archiv, Vol.469 No.2, pp.183-190	DOI
2016-08	Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer Lee, Su Hyun; Ha, Seunggyun; An, Hyun Joon; Lee, Jae Sung; Han, Wonshik; Im, Seock-Ah; Ryu, Han Suk; Kim, Won Hwa; Chang, Jung Min; Cho, Nariya; Moon, Woo Kyung; Cheon, Gi Jeong European Journal of Nuclear Medicine and Molecular Imaging, Vol.43 No.9, pp.1574-1584	DOI
2016-08	New insight on the biological role of p53 protein as a tumor suppressor: re-evaluation of its clinical significance in triple-negative breast cancer Jin, Min-Sun; Park, In Ae; Kim, Ji Young; Chung, Yul Ri; Im, Seock-Ah; Lee, Kyung-Hun; Moon, Hyeong-Gon; Han, Wonshik; Noh, Dong-Young; Ryu, Han Suk Tumor Biology, Vol.37 No.8, pp.11017-11024	DOI
2016-08	Prognostic Significance of Nodal Ratio in Patients Undergoing Adjuvant Chemoradiotherapy After Curative Resection for Ampullary Cancer Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. American Journal of Clinical Oncology, Vol.39 No.4, pp.346-349	DOI
2016-08	Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study Lee, Dong Ho; Kim, Se Hyung; Im, Seock-Ah; Oh, Do-Youn; Kim, Tae-Yong; Han, Joon Koo European Radiology, Vol.26 No.8, pp.2771-2778	DOI
2016-09	Therapeutic implication of HER2 in advanced biliary tract cancer Nam, Ah-Rong; Kim, Ji-Won; Cha, Yongjun; Ha, Hyerim; Park, Ji Eun; Bang, Ju-Hee; Jin, Mei Hua; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Oncotarget, Vol.7 No.36, pp.58007-58021	DOI
2016-10	Phase II trial of dacomitinib in patients with HER2-positive gastric cancer Oh, Do-Youn; Lee, Kewn-Wook; Cho, Jae Yong; Kang, Won Ki; Im, Seock-Ah; Kim, Jin Won; Bang, Yung-Jue Gastric Cancer, Vol.19 No.4, pp.1095-1103	DOI
2016-10	Prognostic value of axillary nodal ratio after neoadjuvant chemotherapy of doxorubicin/cyclophosphamide followed by docetaxel in breast cancer: A multicenter retrospective cohort study Kim, Se Hyun; Jung, Kyung Hae; Kim, Tae-Yong; Im, Seock-Ah; Choi, In Sil; Chae, Yee Soo; Baek, Sun Kyung; Kang, Seok Yun; Park, Sarah; Park, In Hae; Lee, Keun Seok; Choi, Yoon Ji; Lee, Soohyeon; Sohn, Joo Hyuk; Park, Yeon-Hee; Im, Young-Hyuck; Ahn, Jin-Hee; Kim, Sung-Bae; Kim, Jee Hyun Cancer Research and Treatment, Vol.48 No.4, pp.1373-1381	DOI
2016-10	Outcome Analysis of Chemoradiation in Unresectable Pancreatic Cancer Focusing on Treatment Sequencing Strategy Koh, Hyeon Kang; Chie, Eui Kyu; Kim, Kyubo; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Ha, Sung W. Anticancer Research, Vol.36 No.10, pp.5455-5461	DOI
2016-10	Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unit Han, Ji-Min; Ah, Young-Mi; Suh, Sung Yun; Jung, Sun-Hoi; Hahn, Hyeon Joo; Im, Seock-Ah; Lee, Ju-Yeun International Journal of Clinical Pharmacy, Vol.38 No.5, pp.1124-1132	DOI
2016-10	Longitudinal Association of Poor Sleep Quality With Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer Jung, Dooyoung; Lee, Kwang-Min; Kim, Won-Hyoung; Lee, Joo-Young; Kim, Tae-Yong; Im, Seock-Ah; Lee, Kyung-Hun; Spiegel, David; Hahm, Bong-Jin Psychosomatic Medicine, Vol.78 No.8, pp.959-965	DOI
2016-11	Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy Ha, Hyerim; Nam, Ah-Rong; Bang, Ju-Hee; Park, Ji-Eun; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Oncotarget, Vol.7 No.47, pp.76604-76612	DOI
2016-11	Palbociclib and Letrozole in Advanced Breast Cancer Finn, Richard S.; Martin, Miguel; Rugo, Hope S.; Jones, Stephen; Im, Seock-Ah; Gelmon, Karen; Harbeck, Nadia; Lipatov, Oleg N.; Walshe, Janice M.; Moulder, Stacy; Gauthier, Eric; Lu, Dongrui R.; Randolph, Sophia; Dieras, Veronique; Slamon, Dennis J. New England Journal of Medicine, Vol.375 No.20, pp.1925-1936	DOI
2016-11	Pretreatment MR Imaging Features of Triple-Negative Breast Cancer: Association with Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival Bae, Min Sun; Shin, Sung Ui; Ryu, Han Suk; Han, Wonshik; Im, Seock-Ah; Park, In-Ae; Noh, Dong-Young; Moon, Woo Kyung Radiology, Vol.281 No.2, pp.392-400	DOI
2016-11	TTP as a surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: meta-analysis of randomised controlled trials Lee, Dae-Won; Jang, Myoung-Jin; Lee, Kyung-Hun; Cho, Eun Ju; Lee, Jeong-Hoon; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You British Journal of Cancer, Vol.115 No.10, pp.1201-1205	DOI
2016-12	Clonal evolutionary analysis during HER2 blockade in HER2-positive inflammatory breast cancer: A phase II open-label clinical trial of afatinib plus /- vinorelbine Goh, Gerald; Schmid, Ramona; Guiver, Kelly; Arpornwirat, Wichit; Chitapanarux, Imjai; Ganju, Vinod; Im, Seock-Ah; Kim, Sung-Bae; Dechaphunkul, Arunee; Maneechavakajorn, Jedzada; Spector, Neil; Yau, Thomas; Afrit, Mehdi; Ben Ahmed, Slim; Johnston, Stephen R.; Gibson, Neil; Uttenreuther-Fischer, Martina; Herrero, Javier; Swanton, Charles PLoS Medicine, Vol.13 No.12, p. e1002136	DOI
2016-12	Prognostic Significance of Inner Quadrant Involvement in Breast Cancer Treated with Neoadjuvant Chemotherapy Chang, Ji Hyun; Jeon, Wan; Kim, Kyubo; Shin, Kyung Hwan; Han, Wonshik; Noh, Dong-Young; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Journal of Breast Cancer, Vol.19 No.4, pp.394-401	DOI
2016-12	Accelerated whole breast irradiation in early breast cancer patients with adverse prognostic features Lee, Sea-Won; Shin, Kyung Hwan; Chie, Eui Kyu; Kim, Jin Ho; Im, Seock-Ah; Han, Wonshik; Noh, Dong-Young; Lim, Hyeon Woo; Kim, Tae Hyun; Lee, Keun Seok; Lee, Eun Sook; Sung, Soo Yoon; Kim, Kyubo Oncotarget, Vol.7 No.49, pp.81888-81898	DOI
2017-01	Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells Kim, Hee-Jun; Min, Ahrum; Im, Seock-Ah; Jang, Hyemin; Lee, Kyung Hun; Lau, Alan; Lee, Miso; Kim, Seongyeong; Yang, Yaewon; Kim, Jungeun; Kim, Tae Yong; Oh, Do-Youn; Brown, Jeffrey; O'Connor, Mark J.; Bang, Yung-Jue International Journal of Cancer, Vol.140 No.1, pp.109-119	DOI
2017-01	Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Bang, Ju-Hee; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Gastric Cancer, Vol.20 No.1, pp.164-174	DOI
2017-01	Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer Cho, Kyoung-Min; Park, Hyunkyung; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Oncotarget, Vol.8 No.2, pp.2329-2341	DOI
2017-01	Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation Miles, David; Cameron, David; Bondarenko, Igor; Manzyuk, Lyudmila; Alcedo, Juan Carlos; Lopez, Roberto Ivan; Im, Seock-Ah; Canon, Jean-Luc; Shparyk, Yaroslav; Yardley, Denise A.; Masuda, Norikazu; Ro, Jungsil; Denduluri, Neelima; Hubeaux, Stanislas; Quah, Cheng; Bais, Carlos; O'Shaughnessy, Joyce European Journal of Cancer, Vol.70, pp.146-155	DOI
2017-01	Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment An, Eunkyung; Ock, Chan Young; Kim, Tae You; Lee, Kyung Hun; Han, Se Won; Im, Seock Ah; Kim, Tae Yong; Liao, Wei Li; Cecchi, Fabiola; Blackler, Adele; Thyparambil, Sheeno; Kim, W. H.; Burrows, Jon; Hembrough, Todd; Catenacci, Daniel V.T.; Oh, Do Youn; Bang, Yung–Jue Annals of Oncology, Vol.28 No.1, pp.110-115	DOI
2017-03	Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Lee, Joongyub; Bang, Ju-Hee; Lee, Kyung-Hun; Han, Sae-Won; Kim, Tae-Yong; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn Gastric Cancer, Vol.20 No.2, pp.254-262	DOI
2017-03	Optimal Timing of Influenza Vaccination During 3-Week Cytotoxic Chemotherapy Cycles Keam, Bhumsuk; Kim, Min-Kyung; Choi, Yunhee; Choi, Su-Jin; Choe, Pyoeng Gyun; Lee, Kyung-Hun; Kim, Tae Min; Kim, Tae-Yong; Oh, Do-Youn; Kim, Dong-Wan; Im, Seock-Ah; Kim, Nam-Joong; Heo, Dae Seog; Park, Wan Beom; Oh, Myoung-don Cancer, Vol.123 No.5, pp.841-848	DOI
2017-04	Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results Park, Yeon Hee; Kim, Tae Yong; Im, Young-Hyuck; Lee, Keun-Seok; Park, In Hae; Sohn, Joohyuk; Lee, Soo-Hyeon; Im, Seock-Ah; Kim, Jee Hyun; Kim, Se Hyun; Lee, Soo Jung; Koh, Su-Jin; Lee, Ki Hyeong; Choi, Yoon Ji; Cho, Eun Kyung; Lee, Suee; Kang, Seok Yun; Seo, Jae Hong; Kim, Sung-Bae; Jung, Kyung Hae Cancer Research and Treatment, Vol.49 No.2, pp.423-429	DOI
2017-04	Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer in Korea Beom, Seung Hoon; Oh, Jisu; Kim, Tae-Yong; Lee, Kyung-Hun; Yang, Yaewon; Suh, Koung Jin; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Kim, Tae-You; Noh, Dong-Young; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.2, pp.454-463	DOI
2017-04	Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of lmatinib and Sunitinib: A Multicenter Study Based on the Management Access Program Son, Myoung Kyun; Ryu, Min-Hee; Park, Joon Oh; Im, Seock-Ah; Kim, Tae-Yong; Lee, Su Jin; Ryoo, Baek-Yeol; Park, Sook Ryun; Kang, Yoon-Koo Cancer Research and Treatment, Vol.49 No.2, pp.350-357	DOI
2017-04	Phosphorylated Akt expression as a favorable prognostic factor for patients undergoing curative resection and adjuvant chemoradiotherapy for proximal extrahepatic bile duct cancer Kim, Byoung Hyuck; Kim, Kyubo; Min, Hye Sook; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Jang, Ja-June; Ha, Sung W. American Journal of Clinical Oncology, Vol.40 No.2, pp.158-162	DOI
2017-04	Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer Hong, A. R.; Kim, J. H.; Lee, K. H.; Kim, T. Y.; Im, S. A.; Kim, T. Y.; Moon, H. G.; Han, W. S.; Noh, D. Y.; Kim, S. W.; Shin, C. S. Osteoporosis International, Vol.28 No.4, pp.1413-1422	DOI
2017-04	First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors Bang, Y. J.; Giaccone, G.; Im, S. A.; Oh, D. Y.; Bauer, T. M.; Nordstrom, J. L.; Li, H.; Chichili, G. R.; Moore, P. A.; Hong, S.; Stewart, S. J.; Baughman, J. E.; Lechleider, R. J.; Burris, H. A. Annals of Oncology, Vol.28 No.4, pp.855-861	DOI
2017-04	AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells Min, Ahrum; Im, Seock-Ah; Jang, Hyemin; Kim, Seongyeong; Lee, Miso; Kim, Debora Keunyoung; Yang, Yaewon; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Jin Won; Kim, Tae-Yong; Oh, Do-Youn; Brown, Jeff; Lau, Alan; O'Connor, Mark J.; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.16 No.4, pp.566-577	DOI
2017-05	Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial Twelves, Chris; Cortes, Javier; O'Shaughnessy, Joyce; Awada, Ahmad; Perez, Edith A.; Im, Seock-Ah; Gomez-Pardo, Patricia; Schwartzberg, Lee S.; Dieras, Veronique; Yardley, Denise A.; Potter, David A.; Mailliez, Audrey; Moreno-Aspitia, Alvaro; Ahn, Jin-Seok; Zhao, Carol; Hoch, Ute; Tagliaferri, Mary; Hannah, Alison L.; Rugo, Hope S. European Journal of Cancer, Vol.76, pp.205-215	DOI
2017-05	Late chronotypes are associated with neoadjuvant chemotherapy-induced nausea and vomiting in women with breast cancer Lee, Kwang-Min; Jung, Doo-Young; Hwang, Heesung; Kim, Won-Hyoung; Lee, Joo-Young; Kim, Tae-Yong; Im, Seock-Ah; Lee, Kyung-Hun; Spiegel, David; Hahm, Bong-Jin Chronobiology International, Vol.34 No.4, pp.480-491	DOI
2017-06	Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach Kurokawa, Yukinori; Yang, Han-Kwang; Cho, Haruhiko; Ryu, Min-Hee; Masuzawa, Toru; Park, Sook Ryun; Matsumoto, Sohei; Lee, Hyuk-Joon; Honda, Hiroshi; Kwon, Oh Kyoung; Ishikawa, Takashi; Lee, Kyung Hee; Nabeshima, Kazuhito; Kong, Seong-Ho; Shimokawa, Toshio; Yook, Jeong-Hwan; Doki, Yuichiro; Im, Seock-Ah; Hirota, Seiichi; Hahn, Seokyung; Nishida, Toshirou; Kang, Yoon-Koo British Journal of Cancer, Vol.117 No.1, pp.25-32	DOI
2017-06	Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy Masuda, N.; Lee, S. -J.; Ohtani, S.; Im, Y. -H.; Lee, E. -S.; Yokota, I.; Kuroi, K.; Im, S. -A.; Park, B. -W.; Kim, S. -B.; Yanagita, Y.; Ohno, S.; Takao, S.; Aogi, K.; Iwata, H.; Jeong, J.; Kim, A.; Park, K. -H.; Sasano, H.; Ohashi, Y.; Toi, M. New England Journal of Medicine, Vol.376 No.22, pp.2147-2159	DOI
2017-07	Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis Kim, Seongyeong; Min, Ahrum; Lee, Kyung-Hun; Yang, Yaewon; Kim, Tae-Yong; Lim, Jee Min; Park, So Jung; Nam, Hyun-Jin; Kim, Jung Eun; Song, Sang-Hyun; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Kim, Tae-You; Hangauer, David; Lau, Johnson Yiu-Nam; Im, Kyongok; Lee, Dong Soon; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.3, pp.643-655	DOI
2017-07	CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy Lee, Dae-Won; Im, Seock-Ah; Kim, Yu Jung; Yang, Yaewon; Rhee, Jiyoung; Na, Im Ii; Lee, Kyung-Hun; Kim, Tae -Yong; Han, Sae -Won; Choi, In Sil; Oh, Do-Youn; Kim, Jee Hyun; Kim, Tae -You; Bang, Yung-Jue Cancer Research and Treatment, Vol.49 No.3, pp.807-815	DOI
2017-07	Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer Song, Su Jeong; Min, Ji; Suh, Sung Yun; Jung, Sun Hoi; Hahn, Hyeon Joo; Im, Seock-Ah; Lee, Ju-Yeun Supportive Care in Cancer, Vol.25 No.7, pp.2241-2248	DOI
2017-07	Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial Baselga, Jose; Im, Seock Ah; Iwata, Hiroji; Cortes, Javier; De laurentiis, Michele; Jiang, Zefei; Arteaga, Carlos L.; Jonat, Walter; Clemons, Mark; Ito, Yoshinori; Awada, Ahmad; Chia, Stephen; Jagiello-Gruszfeld, Agnieszka; Pistilli, Barbara; Tseng, Ling-Ming; Hurvitz, Sara; Masuda, Norikazu; Takahashi, Masato; Vuylsteke, Peter; Hachemi, Soulef; Dharan, Bharani; Di Tomaso, Emmanuelle; Urban, Patrick; Massacesi, Cristian; Campone, Mario The Lancet Oncology, Vol.18 No.7, pp.904-916	DOI
2017-08	Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation Robson, Mark; Im, Seock-Ah; Senkus, Elzbieta; Xu, Binghe; Domchek, Susan M.; Masuda, Norikazu; Delaloge, Suzette; Li, Wei; Tung, Nadine; Armstrong, Anne; Wu, Wenting; Goessl, Carsten; Runswick, Sarah; Conte, Pierfranco New England Journal of Medicine, Vol.377 No.6, pp.523-533	DOI
2017-08	PALOMA-3: Phase III Trial of Fulvestrant With or Without Palbociclib in Premenopausal and Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That Progressed on Prior Endocrine Therapy-Safety and Efficacy in Asian Patients Iwata, Hiroji; Im, Seock-Ah; Masuda, Norikazu; Im, Young-Hyuck; Inoue, Kenichi; Rai, Yoshiaki; Nakamura, Rikiya; Kim, Jee Hyun; Hoffman, Justin T.; Zhang, Ke; Giorgetti, Carla; Lyer, Shrividya; Schnell, Patrick T.; Bartlett, Cynthia Huang; Ro, Jungsil Journal of Global Oncology, Vol.3 No.4, pp.289-303	DOI
2017-09	EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release Suh, Koung Jin; Sung, Ji Hea; Kim, Jin Won; Han, Song-Hee; Lee, Hye Seung; Min, Ahrum; Kang, Mi Hyun; Kim, Ji Eun; Kim, Ji-Won; Kim, Se Hyun; Lee, Jeong-Ok; Kim, Yu Jung; Lee, Keun-Wook; Kim, Jee Hyun; Bang, Soo-Mee; Im, Seock-Ah; Lee, Jong Seok Oncotarget, Vol.8 No.38, pp.63901-63910	DOI
2017-09	Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results Loibl, Sibylle; Turner, Nicholas C.; Ro, Jungsil; Cristofanilli, Massimo; Iwata, Hiroji; Im, Seock-Ah; Masuda, Norikazu; Loi, Sherene; Andre, Fabrice; Harbeck, Nadia; Verma, Sunil; Folkerd, Elizabeth; Theall, Kathy Puyana; Hoffman, Justin; Zhang, Ke; Bartlett, Cynthia Huang; Dowsett, Mitchell Oncologist, Vol.22 No.9, pp.1028-1038	DOI
2017-09	Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial Cortes, Javier; Rugo, Hope S.; Awada, Ahmad; Twelves, Chris; Perez, Edith A.; Im, Seock-Ah; Gomez-Pardo, Patricia; Schwartzberg, Lee S.; Dieras, Veronique; Yardley, Denise A.; Potter, David A.; Mailliez, Audrey; Moreno-Aspitia, Alvaro; Ahn, Jin-Seok; Zhao, Carol; Hoch, Ute; Tagliaferri, Mary; Hannah, Alison L.; O'Shaughnessy, Joyce Breast Cancer Research and Treatment, Vol.165 No.2, pp.329-341	DOI
2017-09	Randomized Phase III Trial of Trastuzumab Plus Capecitabine With or Without Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Who Experienced Disease Progression During or After Trastuzumab-Based Therapy Urruticoechea, Ander; Rizwanullah, Mohammed; Im, Seock-Ah; Sanchez Ruiz, Antonio Carlos; Lang, Istvan; Tomasello, Gianluca; Douthwaite, Hannah; Crnjevic, Tanja Badovinac; Heeson, Sarah; Eng-Wong, Jennifer; Munoz, Montserrat Journal of Clinical Oncology, Vol.35 No.26, pp.3030-3038	DOI
2017-09	Human Epidermal Growth Factor Receptor 2 Expression in Unresectable Gastric Cancers: Relationship with CT Characteristics Lee, Jeong Sub; Kim, Se Hyung; Im, Seock-Ah; Kim, Min A.; Han, Joon Koo Korean Journal of Radiology, Vol.18 No.5, pp.809-820	DOI
2017-10	Korean Cancer Patients' Awareness of Clinical Trials, Perceptions on the Benefit and Willingness to Participate Lim, Yoojoo; Lim, Jee Min; Jeong, Won Jae; Lee, Kyung-Hun; Keam, Bhumsuk; Kim, Tae-Yong; Kim, Tae Min; Han, Sae-Won; Oh, Do Youn; Kim, Dong-Wan; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.4, pp.1033-1043	view file DOI

1 5 6 7 8 9 10